Editorial

Welcome to the second edition of 2018. This issue features papers from a range of stakeholder perspectives. The first paper by Chester et al. is one of the first to examine the clinical challenges associated with a diagnosis of psychosis in individuals with autism spectrum disorder (ASD), and intellectual disability (ID) using a case series approach. It is generally accepted that early identification and treatment is essential to reduce impact on both present and future quality of life. This case series examines four patients with psychosis, ASD and ID, who have been in receipt of forensic mental health and ID services. In all cases, the use of antipsychotic medication was associated with an improvement in both psychotic symptoms and quality of life. ASD symptoms that were exacerbated as part of the psychosis also fell back to the levels they were pre psychosis.